Metabolic engineering and bioproduction — engineering a pathway to a lab titer is the easy part; commercial-scale $/kg cost-competitiveness is the real bottleneck
Evidence-first notes on bioscience and deep tech, at the edge of the lab and the market. Information only — not investment advice. All titer, yield, carbon-cost, $/kg and capex figures are attributed to the specific strain, conditions, techno-economic (TEA) assumptions or announcement they come from; peer-reviewed data, company claims, trade press and TEA models are…
The quantum-sensing landscape — the most mature corner of quantum technology, but genuine “beats-classical-in-the-field” advantage is narrow, not broad
Evidence-first notes on bioscience and deep tech, at the edge of the lab and the market. Information only — not investment advice. All sensitivity, stability and precision figures are attributed to the specific instrument, trial or company; peer-reviewed results, company claims and agency projections are labeled and kept separate (noted inline). Sensitivities quoted for different…
The fusion commercialization paradox — the private-capital boom is real (a record $4.48bn in 12 months, $14.24bn cumulative), yet that money has moved zero of the outcome-layer metrics that actually gate grid electricity
Evidence-first notes on bioscience and deep tech, at the edge of the lab and the market. Information only — not investment advice. All funding, valuation and roadmap figures are attributed to the industry association, the company, or the primary filing; many are company press releases, SPAC merger figures or association surveys rather than audited or…
Fusion commercialization and economics — the “2030s grid” roadmaps are real, but the bottleneck is timeline and cost, not science; a scientific milestone does not move the LCOE stack
Evidence-first notes on bioscience and deep tech, at the edge of the lab and the market. Information only — not investment advice. There is no operating fusion power plant anywhere in the world, so no measured LCOE, capex or availability exists; every economic figure in this post is a model or an estimate, attributed to…
The fusion physics-to-engineering gap — ignition (Q_plasma>1) is real, but the four outcome-layer constraints it never touches are where commercial fusion is actually decided
Evidence-first notes on bioscience and deep tech, at the edge of the lab and the market. Information only — not investment advice. Q values are always attributed to a device, series and denominator (scientific Q_plasma, engineering Q, or wall-plug Q are not the same number); tritium, materials and duty-cycle figures are attributed to the peer-reviewed…
Magnetic confinement fusion — 2021-2025 delivered energy, triple-product and duration records, but every one is non-Q: no magnetic device has shown Q_plasma>1, and none of any kind has shown Q_engineering>1
Evidence-first notes on bioscience and deep tech, at the edge of the lab and the market. Information only — not investment advice. There is no pure-play listed fusion stock today (Commonwealth Fusion Systems is private). Every figure for energy (MJ), temperature, magnetic field (T), triple product, duration, power (MW) and timeline is attributed to the…
The embodied-AI commercial landscape — a record funding boom coexists with almost no deployed autonomous worker; the bottleneck is the outcome layer (autonomy, robot data, reliability), not the chassis
Evidence-first notes on bioscience and deep tech, at the edge of the lab and the market. Information only — not investment advice. All valuation, funding and market-size figures are attributed to the company announcement, trade press or bank projection as noted inline; private post-money rounds are not audited or market-clearing values, “in-talks” rounds are not…
Embodied AI, Part 4 — the hardware is maturing and the demos and pilots are real, but the true ceiling is the deployment layer: lights-out autonomous reliability and labor-replacement unit economics
Evidence-first notes on bioscience and deep tech, at the edge of the lab and the market. Information only — not investment advice. All deployment, pilot, uptime and cost figures are attributed to their source, and separated into three tiers: peer-reviewed / primary reporting (IEEE Spectrum), company press release or company page (company claim), and secondary…
Embodied AI Part 3 — the data bottleneck: robot foundation models have no internet-scale corpus, and teleop, sim and human video have not closed Goldberg’s 100,000-year gap
Evidence-first notes on bioscience and deep tech, at the edge of the lab and the market. Information only — not investment advice. All dataset sizes, teleoperation costs, simulation-fidelity claims and synthetic-data figures are attributed to the relevant arXiv paper, journal, NVIDIA blog or company announcement. Peer-reviewed sources (Science Robotics, arXiv academic work), company/vendor claims (NVIDIA,…
Robot foundation models / VLA — the “ChatGPT moment for robotics” claim versus what the benchmarks actually measure
Evidence-first notes on bioscience and deep tech, at the edge of the lab and the market. Information only — not investment advice. Every generalization figure below is attributed to the model’s arXiv paper or to a DeepMind / Nvidia / Physical Intelligence / Figure announcement; peer-reviewed and arXiv results are separated from company demos and…
Something went wrong. Please refresh the page and/or try again.
Follow My Blog
Get new content delivered directly to your inbox.
Uthando Nethemba 